Testing LB-102 for adults with acute schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosis of schizophrenia and experiencing an episode that needs hospital care.
- Your symptoms must be moderate to severe (scored 80-120 on a standard test).
- Body Mass Index (BMI) between 18 and 40.
- Willing to stay in the hospital for the study's duration.
- Use effective birth control if sexually active (and not pregnant or breastfeeding).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing how safe and tolerable an investigational medication is over the long term (52 weeks) when added to your current antipsychotic treatment. It's for people with schizophrenia whose symptoms are stable, and it aims to see if the new medication can help without causing serious side effects.
This trial tests an experimental medicine, LTX-001, for people with schizophrenia who are currently having a sudden worsening of symptoms. It aims to see if the drug can help reduce these acute symptoms.
This study tests an experimental medication (NBI-1117570) for adults with schizophrenia who are currently in the hospital because of a sudden worsening of symptoms. The goal is to see if this new treatment can help control symptoms better.
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
This trial tests a new medication (HHK101) for people with stable schizophrenia. It aims to see if the drug is safe and how it works in the body. Participants must be on a steady dose of their current antipsychotic.
This study tests a new medication (LY03020) for people with schizophrenia who are currently having a flare-up of symptoms severe enough to require hospital care. The goal is to see if the drug safely reduces psychotic symptoms like hallucinations and delusions.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.